Loading stock data…
Progyny, Inc. (PGNY)
$28.86+0.35 (+1.23%)
After Hours$28.90+0.04 (+0.14%)· Last close Jun 29
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Progyny, Inc. in the Healthcare sector is trading at $28.86 with a market capitalization of $2.0B. Wall Street consensus targets $30.00 (11 analysts), implying a +4.0% move over the next 12 months. The stock is currently near its 52-week high of $28.99, remaining 29.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $328.50M↑ | $318.40M↑ | $313.35M↓ | $332.87M↑ | $324.04M |
| Gross Profit | $83.07M↑ | $76.88M↑ | $72.83M↓ | $78.97M↑ | $75.80M |
| Operating Income | $35.38M↑ | $15.22M↓ | $21.53M↓ | $24.36M↑ | $24.17M |
| Net Income | $24.23M↑ | $12.48M↓ | $13.86M↓ | $17.11M↑ | $15.06M |
Peer Comparison
JNJUNHPFE
Fundamentals
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cyc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.96B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
32.45
Beta
Defensive asset. Lower volatility than the S&P 500.
0.91
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.41%
Volume
Today's trading volume
1.19M
Recent News
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
What Does the Sale of Progyny Shares by the CFO Mean for Investors?
Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC filings.
1 Russell 2000 Stock for Long-Term Investors and 2 We Turn Down
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders
Progyny recently gained shareholder approval to amend its certificate of incorporation to remove a default supermajority voting requirement for certain business combinations, while also authorizing a US$200,000,000 share repurchase program funded from existing cash. Together with supportive analyst commentary citing solid recent performance, these governance and capital allocation moves highlight management’s confidence and evolving approach to shareholder alignment. We’ll now examine how...
Progyny (PGNY) Authorizes $200M Share Repurchase Program
Progyny, Inc. (NASDAQ:PGNY) is one of the 15 Most Promising Stocks to Buy Right Now. On May 26, 2026, Progyny, Inc. (NASDAQ:PGNY) announced that its Board of Directors approved a share repurchase program to buy back up to $200 million of the company’s common stock. The program will be funded through available cash balances. On […]